BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26691269)

  • 1. Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study.
    Coleman AL; Lum FC; Velentgas P; Su Z; Gliklich RE;
    J Comp Eff Res; 2016 Jan; 5(1):87-98. PubMed ID: 26691269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of laser trabeculoplasty on nocturnal intraocular pressure in medically treated glaucoma patients.
    Lee AC; Mosaed S; Weinreb RN; Kripke DF; Liu JH
    Ophthalmology; 2007 Apr; 114(4):666-70. PubMed ID: 17188360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
    Juncal VR; Abdo Jorge F; Paranhos A; Santos Prata T
    Can J Ophthalmol; 2015 Aug; 50(4):297-301. PubMed ID: 26257224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of intraocular pressure-lowering medication determined by washout.
    Jampel HD; Chon BH; Stamper R; Packer M; Han Y; Nguyen QH; Ianchulev T
    JAMA Ophthalmol; 2014 Apr; 132(4):390-5. PubMed ID: 24481483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical vs medical management of chronic open-angle glaucoma.
    Stewart WC; Sine CS; LoPresto C
    Am J Ophthalmol; 1996 Dec; 122(6):767-74. PubMed ID: 8956630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study.
    Lindén C; Heijl A; Jóhannesson G; Aspberg J; Andersson Geimer S; Bengtsson B
    Acta Ophthalmol; 2018 Sep; 96(6):567-572. PubMed ID: 30242986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy for glaucoma: what to add after a prostaglandin analogs?
    Tanna AP; Lin AB
    Curr Opin Ophthalmol; 2015 Mar; 26(2):116-20. PubMed ID: 25594765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options in primary open-angle glaucoma.
    Wishart P
    Acta Ophthalmol Scand Suppl; 1997; (220):23-8; discussion 28-9. PubMed ID: 9088420
    [No Abstract]   [Full Text] [Related]  

  • 9. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
    Zhang L; Weizer JS; Musch DC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD010746. PubMed ID: 28231380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of several anti-glaucoma medications on the circadian intraocular pressure fluctuations in patients with primary open-angle glaucoma.
    Tanaka S; Watanabe M; Inatomi S; Umeda K; Yoshida K; Ohguro I; Ohguro H
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):12-20. PubMed ID: 24286181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of intraocular pressure in glaucoma patients after automated visual field testing.
    Ni N; Tsai JC; Shields MB; Loewen NA
    J Glaucoma; 2012 Dec; 21(9):590-5. PubMed ID: 21673592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary open-angle glaucoma.
    Goldberg I; Graham SL; Healey PR
    Med J Aust; 2002 Nov; 177(10):535-6. PubMed ID: 12428999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Management of Glaucoma in Exfoliation Syndrome.
    Michalik AZ; Kaufman PL
    J Glaucoma; 2018 Jul; 27 Suppl 1():S87-S90. PubMed ID: 29965902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucoma: a review of adjunctive therapy and new management strategies.
    Whitson JT
    Expert Opin Pharmacother; 2007 Dec; 8(18):3237-49. PubMed ID: 18035966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study.
    Coleman AL; Lum FC; Velentgas P; Su Z; Gliklich RE;
    J Comp Eff Res; 2016 Jan; 5(1):79-85. PubMed ID: 26691017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of glaucoma: focus on pharmacological therapy.
    Marquis RE; Whitson JT
    Drugs Aging; 2005; 22(1):1-21. PubMed ID: 15663346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of medical therapy on IOP control in Ghana.
    Gyasi ME; Andrew F; Adjuik M; Kesse E; Kodjo RA; Herndon L
    Ghana Med J; 2014 Sep; 48(3):148-52. PubMed ID: 25709124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M;
    Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
    Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops.
    Nakakura S; Nomura Y; Ataka S; Shiraki K
    J Glaucoma; 2007 Mar; 16(2):201-4. PubMed ID: 17473730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.